Glaxosmithkline Share News (GSK)

UPDATE 6-U.S. tightens Ebola monitoring for West African visitors

(Adds Obama comments, paragraphs 2, 14-17) By Bill Berkrot NEW YORK, Oct 22 (Reuters) - U.S. health officials imposed fresh constraints on Wednesday on people entering the country from three countries at the center of West Africa's Ebola epidemic, mandating that they report their temp

UPDATE 5-U.S. tightens Ebola monitoring for West African visitors

By Bill Berkrot NEW YORK, Oct 22 (Reuters) - U.S. health officials imposed fresh constraints on Wednesday on people entering the country from three countries at the center of West Africa's Ebola epidemic, mandating that they report their temperature daily and stay in touch with health autho

UPDATE 6-Drugmakers to join forces to make millions of Ebola vaccine doses

* GlaxoSmithKline sees first vaccine doses ready this year * J&J and GSK executives discuss Ebola vaccine collaboration * J&J investing up to $200 mln to accelerate programme * Bavarian Nordic to receive cash injection from J&J * Europe expected to announce funding for new

London close: Markets up on positive company news

The London market closed in positive territory for the second time this week as traders weary of negative economic news took heart from upbeat corporate results. The FTSE 100 Index ended the session 27.4 points ahead at 6399.73 as drug group GlaxoSmithKline pleased investors with news of higher earn

MARKET COMMENT: Corporate Updates Drive Movers As UK Indices Gain

FTSE 100 movers: GlaxoSmithKline leads risers after pleasing with Q3 results

Drug giant Glaxosmithkline (GSK) rose after the pharmaceutical giant said core operating profit fell by just 6% to £1.89bn, compared with the £1.71bn forecast. Figures out from AA Insurance lifted shares in car insurers on Wednesday, with Direct Line and Admiral both parking themselves in the top 10

UPDATE 2-GSK eyes prime FTSE 100 slot for standalone HIV drugs business

* Exploring IPO of minority stake in ViiV Healthcare * GSK dividend to be held at 2014 level in 2015 * Company going through "painful" period as Advair slides * Q3 sales 5.65 bln pounds vs consensus 5.75 bln * Q3 core earnings per share 27.9p vs consensus 23.9p (Adds det

UPDATE 3-U.S. Ebola 'czar' starts work, drugmakers launch vaccine drive

(Adds human testing of possible vaccine, paragraphs 9-10, New Jersey patient cleared, paragraph 17) WASHINGTON, Oct 22 (Reuters) - The new U.S. Ebola "czar" starts work on Wednesday as the Obama administration ramps up its response to the potential spread of the virus, and drugmakers starte

Broker tips: GSK, BHP Billiton, International Personal Finance, Supergroup

Hargreaves Lansdown says the City may take a more charitable view of Glaxosmithkline shares after the drug group announced higher third-quarter earnings per share and a streamlining of its business. The broker said analysts may need to "positively re-evaluate" the market consensus on the shares as a

UPDATE: Glaxo Launches Restructuring As Sliding Advair Sales Hit Profit

Market may need to revisit Glaxo stance, says Hargreaves Lansdown

Hargreaves Lansdown says the City may take a more charitable view of Glaxosmithkline shares after the drug group announced higher third quarter earnings per share and a streamlining of its business. The broker said analysts may need to "positively re-evaluate" the market consensus on the shares as a

BUZZ-Ebola stocks: Drugmakers to collaborate on vaccines

** Shares of companies developing Ebola vaccines rise before the bell ** Leading drugmakers plan to work together to accelerate development of an Ebola vaccine and produce millions of doses of the most effective experimental product for use next year ** Johnson & Johnson aims to produ

GSK sees first Ebola vaccine doses ready late this year

LONDON, Oct 22 (Reuters) - GlaxoSmithKline expects to have the first doses of its Ebola vaccine ready late this year and is looking to work with the rest of the pharmaceutical industry to scale up production. "I fully anticipate that the initial supply should be available before the year en

GlaxoSmithKline Q3 profits fall but EPS up - UPDATE

Drug giant Glaxosmithkline (GSK) announced lower third quarter sales and profits as weak trading in the US and Europe overshadowed a strong performance in emerging markets, although earnings per share rose excluding divestments. GSK said third quarter turnover fell 3% at constant exchange rates and

London midday: UK stocks flat amid central-bank speculation

UK stocks were broadly flat on Wednesday morning after jumping to a one-week high the previous session, as investors reacted to ongoing central-bank speculation and digested mixed corporate earnings. The FTSE 100 was down 0.05% at 6,369 by midday, with results from the likes of British American Toba